ATC
CLVS

Adirondack Trust Company’s Clovis Oncology, Inc. CLVS Stock Holding History

Adirondack Trust Company’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-180
Closed -$10K – 368
2014
Q4 		$10K Sell
180
-25
-12% -$1.31K 0.01% 259
2014
Q3 		$9K Buy
205
+50
+32% +$2.09K 0.01% 269
2014
Q2 		$6K Buy
+155
New +$7.98K ﹤0.01% 288

Other funds holding CLVS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Adirondack Trust Company's CLVS Position: Q1 2015 in Review

Adirondack Trust Company sold out of Clovis Oncology, Inc. (CLVS) in Q1 2015, closing a stake of 180 shares — an estimated $10K sold.

Adirondack Trust Company first reported a position in CLVS in Q2 2014 and held it in 3 quarters. The position peaked at $10K in Q4 2014. 152 funds tracked by Wall St. Rank hold CLVS as of Q1 2015.

  • Adirondack Trust Company reported no remaining Clovis Oncology, Inc. position as of Q1 2015 after selling out during the quarter.
  • Adirondack Trust Company sold 180 Clovis Oncology, Inc. shares in Q1 2015, an estimated $10K.
  • Adirondack Trust Company first reported a position in Clovis Oncology, Inc. in Q2 2014 and held it in 3 quarters.
  • Adirondack Trust Company's Clovis Oncology, Inc. position peaked at $10K in Q4 2014.
  • 152 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q1 2015.

Based on Adirondack Trust Company's 13F filing for Q1 2015, filed 7 Apr 2015.